Latest Advertising And Marketing News

Love Group’s customer cash receipts fell to A$626,000 in the first quarter of FY27, with management blaming a sharp drop in Google Ads return on spend. The company ended September with A$2.014 million in cash and an estimated eight quarters of funding at the latest burn rate.

Frontier Digital Ventures has shrunk its top line by 27% as it exits low-margin businesses, but the reset delivered higher EBITDA, a 17% margin and near-total free cash flow conversion in the first half of FY2026. The next test is whether pricing and cost discipline can lift earnings without further customer erosion.

Zoono Group has reported a 94% jump in quarterly cash receipts to NZ$975K, turning cash flow positive amid expanding commercial rollouts of its shelf-life extension technology across multiple continents.

ReadCloud Limited’s 1H26 results reveal robust growth in school-focused businesses, with cash receipts up 22% and operating cash flow rising 10%, positioning the company to outperform its FY26 earnings guidance.

Biome Australia’s Activated Probiotics brand surpasses one million boxes sold in Australia, approaches top pharmacy ranking, and launches nationally in Canada, setting the stage for FY26 profitability.

Lark Distilling Co. edged up net sales to $4.3 million in Q3 FY26, buoyed by growth in travel retail and B2B channels, while unveiling its new Signature Whisky Range that snagged top design honours.

Love Group Global Ltd reported a 15% decline in quarterly customer cash receipts to $884k in Q3 FY26, driven by a sharp drop in Hong Kong. Despite this, the company maintained positive net operating cash flow and is pursuing growth in US and UK markets.

Zoono Group has boosted its cash receipts by NZ$333,000 this quarter, driven by initial orders worth NZ$585,000 in its fresh food shelf-life extension sector. Despite operating losses, the company expects to sustain operations through signed contracts and inventory.

Cettire Limited reported a 2.8% revenue decline to $382.8 million and a net loss of $1.05 million for the half-year ended 31 December 2025, impacted by softer US demand and rising costs. Despite these headwinds, the company maintains a strong cash position and is focused on profitable growth.

Botanix Pharmaceuticals has launched a A$45 million capital raising to support the expansion of its dermatology product Sofdra®, while negotiating to reduce active pharmaceutical ingredient costs by up to 40%. The raising includes a two-tranche placement and a security purchase plan, with options offered to investors.

Botanix Pharmaceuticals has secured approximately A$45 million through a two-tranche placement and an underwritten security purchase plan to fund API purchases, derisk its supply chain, and accelerate growth of its flagship product Sofdra.

oOh!media has reported solid earnings growth and a higher dividend for 2025, maintaining its leadership in the Out of Home advertising market despite a softer second half. Major contract wins, including Transurban motorway assets, underpin its positive outlook for 2026.